Development of high affinity monobodies recognizing SARS-CoV-2 antigen

Yushen Du(University of California, Los Angeles), Ren Sun(University of California, Los Angeles)

Research Square (Research Square)

April 28, 2020

10.21203/rs.3.rs-25828/v1

Cited by 9

Related Papers

CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity

|Journal for ImmunoTherapy of Cancer|2023|30

Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction

|Journal of Thoracic Oncology|2024|12